Blood markers in preterm babies with breathing problems
Part of Hormones & metabolism, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at two substances in the blood (endocan and copeptin) to see if they can help doctors understand breathing problems in premature babies. It may lead to better ways to care for these infants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born early (preterm).
- Your baby was born between 28 and 36 weeks of pregnancy.
- Your baby has respiratory distress syndrome (a common breathing problem in preemies).
- Your baby does not have certain serious conditions (like growth problems in the womb, brain injury, or birth defects).
- You did not have diabetes or an infection of the membranes during pregnancy (chorioamnionitis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving L-carnitine, a nutrient that helps cells make energy, to premature newborns with respiratory distress syndrome (RDS) can improve their health. It may help their bodies cope better in the NICU.
This study tests a simple non-invasive score that uses blood flow in muscles to predict if a newborn has or will develop high inflammation levels (C-reactive protein). It may help doctors start treatment earlier in babies with breathing problems.
This study compares two types of non-invasive breathing support for premature babies who are having trouble breathing due to underdeveloped lungs. The goal is to see which method works better and helps babies breathe comfortably without needing a breathing tube.
This study tests a new blood marker (called MDW) to help doctors quickly spot late-onset sepsis in preterm babies. If it works, it could lead to faster treatment for infections in premature infants.
This study looks at a blood test that might help check brain injury in newborns who had a lack of oxygen at birth. The test could give doctors more information to help care for your baby.
This study looks at a new way to help very premature babies who need breathing support right after birth. The goal is to find a gentler method that may reduce lung damage and improve breathing outcomes.
Hear when a new Copeptin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.